Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.730
-0.009 (-1.20%)
At close: Dec 5, 2025, 4:00 PM EST
0.713
-0.017 (-2.38%)
After-hours: Dec 5, 2025, 7:05 PM EST
Cytosorbents Market Cap
Cytosorbents has a market cap or net worth of $45.85 million as of December 5, 2025. Its market cap has decreased by -9.91% in one year.
Market Cap
45.85M
Enterprise Value
65.45M
1-Year Change
-9.91%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since December 31, 2007, Cytosorbents's market cap has increased from $5.50M to $45.85M, an increase of 733.70%. That is a compound annual growth rate of 12.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 46.40M | -6.83% |
| Dec 31, 2024 | 49.80M | 1.01% |
| Dec 29, 2023 | 49.30M | -27.07% |
| Dec 30, 2022 | 67.60M | -62.90% |
| Dec 31, 2021 | 182.20M | -47.05% |
| Dec 31, 2020 | 344.10M | 175.72% |
| Dec 31, 2019 | 124.80M | -51.19% |
| Dec 31, 2018 | 255.70M | 37.10% |
| Dec 29, 2017 | 186.50M | 34.37% |
| Dec 30, 2016 | 138.80M | -1.77% |
| Dec 31, 2015 | 141.30M | -38.99% |
| Dec 31, 2014 | 231.60M | 656.86% |
| Dec 31, 2013 | 30.60M | 11.27% |
| Dec 31, 2012 | 27.50M | -3.17% |
| Dec 30, 2011 | 28.40M | 72.12% |
| Dec 31, 2010 | 16.50M | 43.48% |
| Dec 31, 2009 | 11.50M | 475.00% |
| Dec 31, 2008 | 2.00M | -63.64% |
| Dec 31, 2007 | 5.50M | - |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |